A Double-blind Randomized Placebo-controlled Study Comparing Epanova and Fenofibrate on Liver Fat in Overweight Subjects.
Status:
Completed
Trial end date:
2016-05-26
Target enrollment:
Participant gender:
Summary
This study is a double-blind randomized, placebo-controlled, parallel-group, 12 week study
performed in 2 centres in Sweden to assess the effect of Omega-3 carboxylic acids and
fenofibrate on liver fat measured with magnetic resonance imaging (MRI) in patients with
over-weight and hypertriglyceridemia.